9. Anaphylaxis

Journal of Allergy and Clinical Immunology

Volumn 121, Issue 2 SUPPL. 2, 2008, Pages

  Simons, F Estelle R ^a  

^a Section of Allergy and Clinical Immunology   (Canada)

Author keywords

adrenaline; allergic reaction; Anaphylaxis; basophil; epinephrine; Fc RI; food allergy; H1 antihistamine; histamine; IgE; mast cell; medication allergy; tryptase; venom allergy

Indexed keywords

ADRENALIN; ALLERGEN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCAGON; GLUCOCORTICOID; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN E; TRYPTASE;

ANAPHYLAXIS; ARTICLE; COMORBIDITY; EMERGENCY CARE; HUMAN; IMMUNOMODULATION; LABORATORY TEST; PATHOGENESIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SENSITIZATION; SKIN TEST;

ANAPHYLAXIS; EPINEPHRINE; HUMANS; IMMUNOLOGIC TESTS; INJECTIONS; RISK REDUCTION BEHAVIOR;

EID: 38749140296     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.08.061     Document Type: Article

References (40)

1. Sampson H.A., Munoz-Furlong A., Campbell R.L., Adkinson Jr. N.F., Bock S.A., Branum A., et al. Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 117 (2006) 391-397
2. Simons F.E.R., Frew A.J., Ansotegui I.J., Bochner B.S., Finkelman F., Golden D.B.K., et al. Risk assessment in anaphylaxis: current and future approaches. J Allergy Clin Immunol 120 (2007) S2-S24
3. Lieberman P., Camargo Jr. C.A., Bohlke K., Jick H., Miller R.L., Sheikh A., et al. Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol 97 (2006) 596-602
4. Clark S., Gaeta T.J., Kamarthi G.S., and Camargo C.A. ICD-9-CM coding of emergency department visits for food and insect sting allergy. Ann Epidemiol 16 (2006) 696-700
5. Bock S.A., Munoz-Furlong A., and Sampson H.A. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol 119 (2007) 1016-1018
6. Pumphrey R.S.H., and Gowland M.H. Further fatal allergic reactions to food in the United Kingdom, 1999-2006. J Allergy Clin Immunol 119 (2007) 1018-1019
7. Greenberger P.A., Rotskoff B.D., and Lifschultz B. Fatal anaphylaxis: postmortem findings and associated comorbid diseases. Ann Allergy Asthma Immunol 98 (2007) 252-257
8. Prussin C., and Metcalfe D.D. 5. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 117 (2006) S450-S456
9. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponsky A.M., Williams C.M.M., and Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 23 (2005) 749-786
10. Rivera J., and Gilfillan A.M. Molecular regulation of mast cell activation. J Allergy Clin Immunol 117 (2006) 1214-1225
11. Jensen B.M., Metcalfe D.D., and Gilfillan A.M. Targeting kit activation: a potential therapeutic approach in the treatment of allergic inflammation. Inflamm Allergy Drug Targets 6 (2007) 57-62
12. Yokoi H., Myers A., Matsumoto K., Crocker P.R., Saito H., and Bochner B.S. Alteration and acquisition of Siglecs during in vitro maturation of CD34+ progenitors into human mast cells. Allergy 61 (2006) 769-776
13. Olivera A., Mizugishi K., Tikhonova A., Ciaccia L., Odom S., Proia R.L., et al. The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis. Immunity 26 (2007) 287-297
14. Plager D.A., Weiss E.A., Kephart G.M., Mocharla R.M., Matsumoto R., Checkel J.L., et al. Identification of basophils by a mAb directed against pro-major basic protein 1. J Allergy Clin Immunol 117 (2006) 626-634
15. Chang T.W., and Shiung Y.-Y. Anti-IgE as a mast cell-stabilizing therapeutic agent. J Allergy Clin Immunol 117 (2006) 1203-1212
16. Finkelman F.D., Rothenberg M.E., Brandt E.B., Morris S.C., and Strait R.T. Molecular mechanisms of anaphylaxis: lessons from studies with murine models. J Allergy Clin Immunol 115 (2005) 449-457
17. Simons F.E.R. Anaphylaxis, killer allergy: long-term management in the community. J Allergy Clin Immunol 117 (2006) 367-377
18. Schwartz L.B. Diagnostic value of tryptase in anaphylaxis and mastocytosis. Immunol Allergy Clin North Am 26 (2006) 451-463
19. Vadas P., Gold M., Perelman B., Liss G., Lack G., Blyth T., et al. Platelet-activating factor, PAF-acetylhydrolase and severe anaphylaxis. N Engl J Med 358 (2008) 28-35
20. Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology, Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol 115 (2005) S483-S523
21. Golden D.B.K. Insect sting allergy and venom immunotherapy: a model and a mystery. J Allergy Clin Immunol 115 (2005) 439-447
22. Golden D.B.K., Kagey-Sobotka A., Norman P.S., Hamilton R.G., and Lichtenstein L.M. Outcomes of allergy to insect stings in children, with and without venom immunotherapy. N Engl J Med 351 (2004) 668-674
23. Klein-Tebbe J., Erdmann S., Knol E.F., MacGlashan Jr. D.W., Poulsen L.K., and Gibbs B.F. Diagnostic tests based on human basophils: potentials, pitfalls and perspectives. Int Arch Allergy Immunol 141 (2006) 79-90
24. Jappe U., Raulf-Heimsoth M., Hoffmann M., Burow G., Hubsch-Muller C., and Enk A. In vitro Hymenoptera venom allergy diagnosis: improved by screening for cross-reactive carbohydrate determinants and reciprocal inhibition. Allergy 61 (2006) 1220-1229
25. Golden D.B.K., Breisch N.L., Hamilton R.G., Guralnick M.W., Greene A., Craig T.J., et al. Clinical and entomological factors influence the outcome of sting challenge studies. J Allergy Clin Immunol 117 (2006) 670-675
26. Muller U.R., and Haeberli G. Use of beta-blockers during immunotherapy for Hymenoptera venom allergy. J Allergy Clin Immunol 115 (2005) 606-610
27. Stumpf J.L., Shehab N., and Patel A.C. Safety of angiotensin-converting enzyme inhibitors in patients with insect venom allergies. Ann Pharmacother 40 (2006) 699-703
28. Sicherer S.H., and Sampson H.A. 9. Food allergy. J Allergy Clin Immunol 117 (2006) S470-S475
29. Sampson H.A. Update on food allergy. J Allergy Clin Immunol 113 (2004) 805-819
30. Greenberger P.A. 8. Drug allergy. J Allergy Clin Immunol 117 (2006) S464-S470
31. Castells M. Desensitization for drug allergy. Curr Opin Allergy Clin Immunol 6 (2006) 476-481
32. Akdis M., and Akdis C.A. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 119 (2007) 780-791
33. Leung D.Y.M., Sampson H.A., Yunginger J.W., Burks Jr. A.W., Schneider L.C., Wortel C.H., et al. Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med 348 (2003) 986-993
34. Simons F.E.R. Anaphylaxis: evidence-based long-term risk reduction in the community. Immunol Allergy Clin North Am 27 (2007) 231-248
35. Lieberman P. Biphasic anaphylactic reactions. Ann Allergy Asthma Immunol 95 (2005) 217-226
36. Simons F.E.R. First-aid treatment of anaphylaxis to food: focus on epinephrine. J Allergy Clin Immunol 113 (2004) 837-844
37. Rawas-Qalaji M.M., Simons F.E.R., and Simons K.J. Sublingual epinephrine tablets versus intramuscular injection of epinephrine: dose-equivalence for potential treatment of anaphylaxis. J Allergy Clin Immunol 117 (2006) 398-403
38. Kounis N.G. Kounis syndrome (allergic angina and allergic myocardial infarction): a natural paradigm?. Int J Cardiol 110 (2006) 7-14
39. 1-antihistamines for the treatment of anaphylaxis with and without shock. Cochrane Database Syst Rev 1 (2007) CD006160
40. 1-antihistamines. N Engl J Med 351 (2004) 2203-2217